ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•20 Dec 2024 06:00

ASX Short Interest Weekly (Dec 13th): Pilbara Minerals, Xero, Apa, Coles, Wisetech Global

We analyzed ASX short interest report for the past week and highlight short interest changes in Pilbara Minerals, Xero, Apa, Coles, Wisetech Global.

Logo
622 Views
Share
bullish•Grifols SA
•20 Nov 2024 16:18

Lowball Non-Binding Indication from Brookfield

Rejected Offer: Grifols' independent committee rejected Brookfield's proposed valuation of €10.50 per Class A share, citing significant...

Share
•13 Sep 2024 06:00

ASX Short Interest Weekly (Sep 6th): Macquarie, Fortescue, Mirvac, Insurance Australia, BHP

We analyzed ASX short interest report for the past week and highlight short interest changes in Macquarie, Fortescue, Mirvac, Insurance Australia,...

Logo
560 Views
Share
•06 Sep 2024 12:00

ASX Short Interest Weekly (Aug 30th): Fortescue, Woodside Energy, National Australia Bank, Westpac

We analyzed ASX short interest report for the past week and highlight short interest changes in Fortescue, Woodside Energy, National Australia...

Logo
595 Views
Share
•30 Aug 2024 06:00

ASX Short Interest Weekly (Aug 23rd): Goodman, Fortescue, Bluescope Steel, Westgold Resources

We analyzed ASX short interest report for the past week and highlight short interest changes in Goodman, Fortescue, Bluescope Steel, Westgold...

Logo
431 Views
Share
x